BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

FRA:BX2 (USA)  
€ 1.71 (-4.48%) May 24
At Loss
Market Cap:
€ 64.56M ($ 70.08M)
Enterprise V:
€ 90.31M ($ 98.03M)
Volume:
450.00
Avg Vol (2M):
2.63K
Also Trade In:

BioXcel Therapeutics Inc Operating Data

BioXcel Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

BioXcel Therapeutics Inc (FRA:BX2) Operating Data Charts